Niki BioSolutions, Inc. (NIKI) vs Exicure, Inc. (XCUR)
- Niki BioSolutions, Inc. NIKI 2.03 −8.56%
- Exicure, Inc. XCUR 1.11 −0.89%
Niki BioSolutions, Inc. and Exicure, Inc. are both Biotechnology companies. Niki BioSolutions, Inc. and Exicure, Inc. are of similar size ($7.3M and $6.9M). Exicure, Inc. grew revenue faster over the last twelve months: 2,366.5% against 42.6%. Exicure, Inc. has the higher net margin (0.00% vs −921.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Exicure, Inc. leads on 8 and Niki BioSolutions, Inc. on 5.
Valuation
Profitability
| Metric | NIKI | XCUR | Biotechnology median |
|---|---|---|---|
| Gross margin | (87.96%) | 80.08% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (921.74%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (168.37%) | (56.36%) |
| Return on assets | 0.00% | (54.98%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack